Interní Med. 2009; 11(7): 332-335

Postinfectious irritable bowel syndrom

prof. MUDr. Milan Lukáš CSc
IV. interní klinika VFN a 1. LF UK, Praha

The functional bowel disorders including the irritable bowel syndrome are the final diagnosis in significant proportion of gastroenterological

patients. The irritable bowel syndrome is characterised by changes of bowel habits with abdominal dyscomfort or abdominal

pain. The pathophysiology of irritable bowel syndrome is still not completely understood. Recently, it has been proved that in 20–30 %

of patients with irritable bowel syndrome the infectious gastroenteritis preceded the clinical manifestation of the bowel functional

disoorder. The bacterial infections (campylobacteriosis, shigelosis and salmonelosis) are considered as the most important causes for

irritable bowel syndrome development. The gastrointestinal infections might induced the abnormal motility pattern which includes

the pathologic gastro-colic reflex and a visceral hyperalgesia. It has been stressed, that coincidental psychiatric illness eg depression or

anxiety and panic neurosis are very important permisive factors for irritable bowel syndrome development.

Therapy of irritable bowel syndrome has to be complex, and symptomatic. Dietary and life style arrangement are very important. The

drug therapy include antidiarrheal agents (diphenyloxylate, loperamide, cholestyramine), tricyclic antidepressants, neuroleptics, and

also musculotropic antispasmodics. Especially in the postinfectious irritable bowel syndrome the long therm therapy with cholestiramine

has been shown as a effective therapy.

Keywords: irritable bowel syndrome, functional bowel disorders, gastrointestinal infections.

Published: September 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lukáš M. Postinfectious irritable bowel syndrom. Interní Med. 2009;11(7):332-335.
Download citation

References

  1. Sayto IA, Schoenfeld P, Locke GR III, et al. The epidemiology of the irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002; 97: 1910-1915. Go to original source... Go to PubMed...
  2. Powel R. On certain painfull affications of the intestinal canal. Med Trans Coll Phys 1818; 6: 106-117. Go to original source...
  3. Howship J. Practical remarks on the discrimination and successful treatment of the spasmodic stricture of the colon. London: Burgess and Hill, 1830.
  4. Chaudhary NA, Truelove SC. The irritable colon syndrome. Q J Med 1962; 31: 307-322.
  5. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-1988. Go to original source... Go to PubMed...
  6. Longstreth GF, Thompson WG, Chey W, et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491. Go to original source... Go to PubMed...
  7. Dizdar V, Gilja OH, Hausken T. Increased visceral senzitivity in Giardia induced postinfectious irritable bowel syndrome and functional dyspepsia. Effects of the 5-HT3 antagonist olasetron. Neurogastroenterol Motil 2007; 19: 977-982. Go to original source... Go to PubMed...
  8. Marshall JK, Thabane M, Borganokar MR James C. Postinfectious irritable bowel syndrome after a food-born outbreak of acute gastroenteritis atributed to viral pathogen. Clinical Gastro Hepatol 2007; 5: 457-460. Go to original source... Go to PubMed...
  9. Halvorson HA, Schlett CD, Riddle MS. Postinfectious irritabale bowel syndrome. Am J Gastroenterol 2006; 101: 1894-1899. Go to original source... Go to PubMed...
  10. Grover M, Herfarth H, Drossman DA. The functional - organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastro Hepatol 2009; 7: 48-53. Go to original source... Go to PubMed...
  11. Barbara G, Cremon C, Palotti F, et al. Postinfectious irritable bowel syndrome, JPGN 2009; 48: S95-S97. Go to original source... Go to PubMed...
  12. Drossman DA. Mind over matter in the postinfectious irritable bowel syndrome. Gut 1999; 44: 306-307. Go to original source... Go to PubMed...
  13. Saito-Nakaya S, Hasegawa R, Nagura Y, et al. Corticotropin releasing hormone receptor 1 antagonist blocks colonic hypersensitivity induced by a combination of inflammation and repetitive colorectal distension. Neurogastroenteral Motil 2008; 20: 1147-1156. Go to original source... Go to PubMed...
  14. Spiler RC. Role of infection in irritable bowel syndrome. J Gastroenterol 2007; 42: 41-47. Go to original source... Go to PubMed...
  15. Colins SM, Ismail M. Irritable bowel syndrome. Evidence-Based Gastroenterology. Edited by: Irvine EJ, Hunt RH. BC Decker Inc, Hamilton, London 2001.
  16. Lukáš M. Muskulotropní spasmolytika a spasmoanalgetika. In Remedia compendium. Třetí vydání. Panax 1999.
  17. Obrtlík M. Spasmolytika v gastroenterologii. Remedia, 2002; 12 (1): 41-49.
  18. Niaz SK, Saandrasegaran K, Renny FH, et al. Postinfective diarrhea and bile acid malabsorption. J R Coll Phys Lond 1997; 31: 53-56.
  19. Spiler R, Aziz Q, Creed F, et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007; 56: 1770-1798. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.